ArticleBreast cancer (Tokyo, Japan)2020

Anti-cell growth and anti-cancer stem cell activity of the CDK4/6 inhibitor palbociclib in breast cancer cells.

Emi Kishino et al.PubMed ↗Publisher ↗

No numbers read from the abstract.